about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureRegulation of cardiac autophagy by insulin-like growth factor 1Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysisRegulation of pyruvate metabolism and human diseaseMetabolomic profiling analysis reveals chamber-dependent metabolite patterns in the mouse heart.Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice.Emerging role of liver X receptors in cardiac pathophysiology and heart failure.Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.Transient decrease in serum potassium level during ischemic attack of acute coronary syndrome: paradoxical contribution of plasma glucose level and glycohemoglobinModulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrateMolecular and metabolic mechanisms of cardiac dysfunction in diabetes.Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.Measuring changes in substrate utilization in the myocardium in response to fasting using hyperpolarized [1-(13)C]butyrate and [1-(13)C]pyruvate.Epigenetic regulation in heart failure.Normal cardiac function in mice with supraphysiological cardiac creatine levelsTaxonomy of segmental myocardial systolic dysfunction.Insulin resistance and heart failure: molecular mechanismsRegulation of cellular gas exchange, oxygen sensing, and metabolic control.Metabolic remodeling in chronic heart failure.Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.Glucose oxidation positively regulates glucose uptake and improves cardiac function recovery after myocardial reperfusion.Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.Dynamic adaptation of myocardial proteome during heart failure developmentThe thermogenic actions of natriuretic peptide in brown adipocytes: The direct measurement of the intracellular temperature using a fluorescent thermoprobe.Rapid induction of aldosterone synthesis in cultured neonatal rat cardiomyocytes under high glucose conditions.IGF-1 and NT-proBNP in a black and white population: The SABPA study.Cardiac Insulin Signaling Regulates Glycolysis Through Phosphofructokinase 2 Content and Activity.Genetic deletion of aquaporin-1 results in microcardia and low blood pressure in mouse with intact nitric oxide-dependent relaxation, but enhanced prostanoids-dependent relaxation.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment.Polymer Functionalization of Isolated Mitochondria for Cellular Transplantation and Metabolic Phenotype Alteration.A Similar Metabolic Profile Between the Failing Myocardium and Tumor Could Provide Alternative Therapeutic Targets in Chemotherapy-Induced Cardiotoxicity.The Cardio- and Neuroprotective Effects of Corvitin and 2-Oxoglutarate in Rats with Pituitrin-Isoproterenol-Induced Myocardial DamageMetabolic Modulation of Cardiac Metabolism in Heart Failure
P2860
Q26745026-4DF13682-9A6B-4C1A-8D03-3D9D7D6B4E17Q27025162-1E566B41-AD65-40BC-AEB9-A8A9E6399906Q33740348-B7604FC9-C5EA-4DAE-865E-93511FD2FB5CQ33764544-140FCE46-6A24-4F03-8737-B074B3CCB9C2Q34781444-D1DDC00C-155A-4C07-BD45-2CE3254D5DCCQ35080694-14677A79-A461-488F-8E63-294A0022090DQ35088508-31E3330F-9408-42E6-9344-2463D7392351Q35677381-FD0D0D25-E212-427B-B3FC-69CAE1633594Q36322805-B7F479EA-6D4D-4320-80A9-F3DA3C74B392Q36353539-C0C5EF68-D648-4128-893E-1611C5481637Q36578795-A20FF11D-7703-4D8E-93BC-77042425D3AEQ36592548-5D993A27-9699-47AB-9E44-86FB299341E6Q36674142-52478433-5593-4068-8EF7-EEED0E05F60DQ36797382-1FACA32E-DFA9-4247-87EE-6F24B3A989ADQ36875198-B95E29FA-3CDD-4D0A-8157-7404C16CCEC0Q37114038-61478E9F-CEA4-44C0-B8ED-D3BD35CB2B22Q37575876-CCB580A1-71C0-4FC6-9F35-3CCCC9A4FCF3Q37738593-57B065C5-92F7-4851-A755-450F7EBC7D6FQ38045550-92D6236A-0424-42A4-92DC-DA8E58CC8178Q38125147-D7CC3DDC-75D3-492F-B2C8-34E99F399F72Q38125159-2161841A-D7BD-43E3-959F-CFE3101E0503Q38371888-251EBB50-457A-4BB4-BA34-30F426AADC6DQ38888754-DCB4BCC0-B2CE-4D9E-8046-83D5D323E00DQ39250080-B686CAEC-78FF-4FF2-81DA-EDED81305021Q42369675-F980293E-D8E3-43DB-982E-4587B0C49D2AQ42374834-CC38D0D4-36F7-4720-A767-5DEFA69C1C6AQ43537312-955FDC49-3800-4077-8E0C-94283526D674Q46808848-2D18114A-AE7F-4BAF-9776-DF8CE6E7ED5FQ47332502-F4668A8E-E978-4956-BF02-91515BA54C56Q47966984-6401269C-E645-4800-A9BE-13B648AC525FQ49247394-819DF998-5628-41C0-B771-C8802686D800Q52313611-9EDA0F36-98AA-4B22-AAC9-9CF8C608B9C5Q52624291-5DAC73F0-3194-4691-A795-002321268B21Q55313684-C668DB3A-0DDE-4DCB-B03A-D554A92683E5Q58766836-40641290-06C4-492A-82BA-A992C5C9B408Q58804689-73DE18F4-5A23-4A62-B36B-C0B57FE733DD
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimization of cardiac metabolism in heart failure
@ast
Optimization of cardiac metabolism in heart failure
@en
Optimization of cardiac metabolism in heart failure
@nl
type
label
Optimization of cardiac metabolism in heart failure
@ast
Optimization of cardiac metabolism in heart failure
@en
Optimization of cardiac metabolism in heart failure
@nl
prefLabel
Optimization of cardiac metabolism in heart failure
@ast
Optimization of cardiac metabolism in heart failure
@en
Optimization of cardiac metabolism in heart failure
@nl
P2093
P2860
P921
P3181
P1476
Optimization of cardiac metabolism in heart failure
@en
P2093
Lopaschuk GD
Mochizuki S
Yoshimura M
P2860
P304
P3181
P356
10.2174/138161211798357773
P407
P5008
P577
2011-12-01T00:00:00Z